Novo Nordisk CEO: Oral Semaglutide Launch In 2020, Novel Obesity Drugs Sought

 
• By Sten Stovall
NovoNordisk
Novo Nordisk reported strong 1Q sales, with newly launched products Ozempic and Saxenda leading the way • Source: Shutterstock

More from Earnings

More from Business